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for the specificity of the Drosophila pro-
teins could be interactions with other
chromatin components that are also en-
riched in RED chromatin.
Follow-up experiments will improve our
understanding of these intriguing new
colors of chromatin and their interplay
with DNA-binding factors. Combined
with data on other epigenomic variables
such as replication initiation (Gilbert,
2001), repair (Groth et al., 2007), nucleo-
somal turnover (Henikoff, 2008), and
three-dimensional genome organization
(Cockell and Gasser, 1999), these results184 Cell 143, October 15, 2010 ª2010 Elseviwill lead to a more comprehensive picture
of chromatin architecture and function.
Clearly, it is time to say goodbye to the
black and white world of heterochromatin
and euchromatin.REFERENCES
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Gene profiling experiments have revealed similarities between cancer and embryonic stem (ES)
cells. Kim et al. (2010) dissect the gene expression signature of ES cells into three functional
modules and find that the Myc module, including genes targeted by Myc-interacting proteins,
accounts for most of the similarity between ES and cancer cells.Modern techniques in stem cell biology in
the postgenomic era have led to dramatic
advances in our understanding of the
molecular underpinnings of both embry-
onic stem (ES) cells and cancer. Several
essential ‘‘core’’ pluripotency genes regu-
lating the ES cell fate (including Oct4,
Sox2, and Nanog) have been defined in
both mice and humans, and biologists
are now using gene expression profiling
experiments to discover genome-wide
‘‘signatures’’ for ES and cancer cells.
Intriguing similarities between ES cells
and cancer have arisen in such experi-
ments, suggesting that cancers and ES
cells may share fundamental mechanisms
for self-renewal and differentiation (Ben-
Porath et al., 2008; Somervaille et al.,
2009; Wong et al., 2008). On the otherhand, the similarity in gene expression
between some cancers and ES cells has
beenpuzzlingbecause a core ‘‘stemness’’
signature that is shared between ES cells
and other tissue stem cells has remained
elusive (Fortunel et al., 2003). In addition,
most human tumors do not exhibit true
pluripotency. So, how can we explain the
similarities in gene expression patterns
between ES and cancer cells?
In this issue of Cell, Kim et al. address
this question by carefully scrutinizing the
ES cell signature and breaking it down
into several functional units. Using this
approach, the authors show that the
connections between ES cells and cancer
are largely due to Myc, the well-studied
proto-oncogene that regulates many
aspects of gene expression, proliferation,and differentiation in adult tissues (Kim
et al., 2010).
Using a powerful, highly stringent, and
innovative in vivo biotinylation technique
to probe protein-protein and protein-
DNA interactions (Kim et al., 2009), the
authors begin by defining a Myc-centered
protein interaction network in mouse ES
cells. They show that this Myc complex
likely interacts with the NuA4 histone
acetyltransferase (HAT) complex, a highly
conserved protein complex involved in
diverse functions, including histone acet-
ylation. This suggests an important role
for Myc in epigenetic regulation in ES
cells. The authors then use chromatin
immunoprecipitation (ChIP) to define
the transcriptional targets of this Myc
complex. Myc targets with the most
Figure 1. Components of the ES Cell Signature
Kim et al. (2010) analyze the regulatory regions of target genes for transcription factor co-occupancy.
By analyzing chromatin immunoprecipitation (ChIP) data from their own experiments on the Myc protein
complex in embryonic stem (ES) cells and other published ChIP experiments on different transcription
factors in ES cells, they separate the ES cell transcriptional signature (far left) into three distinct modules
(indicated in the gray box): the Myc module (green), the Polycomb module (blue), and the Core module
(red). The authors then analyze the expression levels of these modules in various scenarios. High expres-
sion of the Myc module (green bars) is a shared property of ES cells, induced pluripotent stem (iPS) cells,
short-term hematopoietic stem cells (ST-HSCs), and various cancers. However, long-term hematopoietic
stem cells (LT-HSCs) and differentiated ES cells exhibit low Myc module expression. Of note, the Core
(red) module—those genes targeted by Oct4, Sox2, and Nanog—is only predominant in ES and iPS cells.Myc-associated factors bound to their
regulatory regions are positively associ-
ated with epigenetic marks of active chro-
matin—H3 and H4 histone acetylation
and H3K4 trimethylation—consistent
with their data suggesting a connection
between Myc and epigenetic regulation.
Kim et al. then use this Myc complex
ChIP data set and other previously pub-
lished ChIP experiments to obtain a more
complete characterization of the targets
of important transcription factors in ES
cells. From there, they define three sepa-
rate target gene modules based on factor
co-occupancy in the regulatory regions of
those target genes (Figure 1). Together,
these modules constitute the ES gene
expression signature: a Polycomb cluster
(genes bound by the Polycomb complex
factors), a Core cluster (genes targetedby the core pluripotency factors Oct4,
Sox2, and Nanog), and a Myc cluster
(genes targeted by the Myc-interacting
proteins). These modules appear to be
functionally significant, as they behave
independently in different scenarios, such
as during ES cell differentiation. Although
previous studies had suggested that the
Myc pathway is a major component of
the link between ES cells and some
cancers (Wong et al., 2008), it remained
unclear whether Myc activates funda-
mental core ES cell programs such as
pluripotency and self-renewal in both
contexts or whether the Myc pathway is
coincidentally utilized for other reasons
by both ES cells and some cancers. The
current study by Kim et al. clarifies this
point and suggests the latter to be the
case.Cell 143After defining these three separate
gene expression submodules, the authors
analyze gene expression data from sev-
eral different cancers in bothmice and hu-
mans to obtain a more precise under-
standing of how the ES cell signature
relates to gene expression changes in
cancer. This analysis shows that the
Myc module is highly expressed and
dominant in multiple scenarios: Myc-
transformed human epithelial cancers,
several mouse myeloid leukemias, some
human bladder cancers, and some
human breast cancers. Of interest, the
Core ES cell module is not significantly
expressed in these situations. Thus, in
the end,Myc–rather than the core pluripo-
tency factors or the Polycomb proteins—
seems to be the common thread that ties
ES cells to cancer. But what is Myc’s
precise role in ES cells and these cancers,
particularly as it relates to self-renewal,
a hallmark of stem cells? Is it inhibiting
differentiation (Prochownik and Kukow-
ska, 1986), regulating apoptosis, con-
trolling proliferation, or performing some
other function or some combination of
functions?
Although Myc may affect self-renewal
capacity in ES cells and cancer, it may
not be a central player in this process.
For example, although Myc can increase
the efficiency of the generation of induced
pluripotent stem (iPS) cells, it is not strictly
required for reprogramming (Jaenisch
and Young, 2008). In agreement with this
finding, Kim et al. convincingly demon-
strate that theMycmodule is independent
of the core pluripotency module in ES and
iPS cells. Similarly, they show that, in the
normal mouse hematopoietic system,
the Myc module appears to segregate
away from the property of long-term
self-renewal. Specifically, the Myc mod-
ule is upregulated in highly proliferative
short-term hematopoietic stem cells
(bearing the marker profile LincKit+
Sca1+CD34+)—which are more akin to
progenitors, given that they lack sus-
tained self-renewal—and not in themostly
quiescent long-term self-renewing hema-
topoietic stem cells (Lin-cKit+Sca1+
CD34), which do not exhibit Myc module
expression. Thus, in the hematopoietic
lineage, the proliferating progenitor is
actually the cell that upregulates Myc
targets rather than the self-renewing
stem cell. This suggests that the presence, October 15, 2010 ª2010 Elsevier Inc. 185
of the Myc module in gene expression
signatures from ES cell populations and
poor prognosis cancers may be more of
a reflection of the active proliferation
occurring in both rather than self-renewal.
In cancer, Myc’s relationship to self-
renewal is complex (Arvanitis and Felsher,
2006), and sometimes Myc expression
maycorrelatewith self-renewal. For exam-
ple, the authors show that, in various
mouse models of acute myelogenous
leukemia (AML), the activity of the Myc
module trends with the frequency of
self-renewing leukemia-initiating cells.
Although these findings could potentially
be explained by the closer resemblance
of the leukemia-initiating cells in AML to
progenitors rather than hematopoietic
stem cells (Majeti et al., 2007), further
work on Myc is needed to decipher its
precise role(s) in the regulation of prolifera-
tion, apoptosis, or differentiation in various186 Cell 143, October 15, 2010 ª2010 Elsevistem cell settings, including ES cells, iPS
cells, adult stem cells, and cancer cells.
Ultimately, by focusing on factor co-
occupancy of target genes in ES cells
and thereby taking a modular look at
gene expression in ES cells and cancer,
this paper helps us to understand the
basis for their similarities. It illustrates the
important role of Myc and will likely spur
cancer biologists to further clarify the
precise role of Myc in tumor biology, a
question with potential therapeutic ramifi-
cations (Arvanitis and Felsher, 2006).REFERENCES
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